Total Pageviews

Tuesday 4 February 2014

U.K. insulin use trebles in twenty years as diabetes rates increase

In the United Kingdom the estimated number of people with diabetes has risen from 1.4 million to 2.8 million between 1996 and 2010, and new research in Diabetes, Obesity and Metabolism has found that insulin use has trebled across the population in the last twenty years.
The financial cost of insulin to the National Health Service increased from £156 million in 2000 to £359 million in 2009, due in part to the introduction of more expensive insulin analogues and the more frequent use of insulin by type 2 diabetics.
The research team, based at the University of Cardiff, aimed to calculate the rise of insulin use in type 1 and type 2 diabetics in the U.K. They turned to the Clinical Practice Research Datalink, which holds data for 12 million patients registered across 660 practices.
The results show an increase in the rate of insulin use from 2.43 per 1,000 population in 1991 to 6.71 per 1,000 in 2010.
"The number of people using insulin trebled between 1991 and 2010, largely due to a considerable increase in the number of people with type 2 diabetes using insulin," said Professor Craig Currie from Cardiff University. "The rising prevalence of insulin use probably reflects both increasing incidence and longer survival of those who already have type 2 diabetes."

Not unexpected given the lunacy of the dietary advice for Type 2 diabetes.

Graham

1 comment:

Lowcarb team member said...

Only a few years ago the NHS thought it was the best thing for T2s to be on insulin as soon as possible. In my PCT area the GP surgeries were offered financial incentives to put T2s, even those with HBA1cs within target onto insulin.

I don't think this was confined to my area as it was a RCN initiative. All hospital staff with the faintest connection with diabetes from Hca to Consultant were also targeted. In my Practice they were very aggressive about it.

Now this has changed. For whatever reason. I should like to think that recent studies warning of the dangers had been taken on board but I don't think this is the case. It's more likely that it's too costly without bringing any benefits - not surprising with T2s with adequate control.

I will be interested to see if figures in a few years time reflect this change in policy.

Kath